ACETAMINOPHENASSAY

Patent europeic · EP3813812 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3813812
Numer da la dumonda
EP19797109
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
03-05-2019
Publitgà
05-05-2021
Concedì
03-12-2025
La protecziun finescha il pli tard
02-05-2039
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
A61K 31/167 (2006.01)
C12Q 1/34 (2006.01)
G01N 21/78 (2006.01)
G01N 33/52 (2006.01)
G01N 33/53 (2006.01)
G01N 33/58 (2006.01)
Prioritad
US 201862666282 P 03.05.2018
Dumonda PCT
PCT/US2019/030558 03.05.2019
Publicaziun PCT
WO2019/213489 07.11.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 14-10-2026

    Midada

    Published in Swissreg on 14.10.2026

  2. 01-06-2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 01.06.2026

  3. 05-12-2025

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 05.12.2025

  4. 03-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.12.2025

Partidas

Possessur

Sekisui Diagnostics, LLC

One Wall Street, Burlington, MA 01803, US

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

ACORN, Robert

Charlottetown, PE, C1E 2B9, CA

COADY, Helen

Charlottetown, PE, C1E 2B9, CA

COLL, Graham

Charlottetown, PE, C1E 2B9, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.